Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-04-29

FDA Approved: LEFLUNOMIDE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex Corp.'s supplemental application for Leflunomide (generic). This confirms an approved change under the Abbreviated New Drug Application for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leflunomide (Leflunomide)

Snippet

SUPPL AP for LEFLUNOMIDE (LEFLUNOMIDE)